Net profit of Emmessar Biotech & Nutrition rose 40.00% to Rs 0.28 crore in the quarter ended September 2024 as against Rs 0.20 crore during the previous quarter ended September 2023. Sales rose 325.00% to Rs 0.34 crore in the quarter ended September 2024 as against Rs 0.08 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales0.340.08 325 OPM %-23.53-275.00 - PBDT0.430.31 39 PBT0.410.29 41 NP0.280.20 40 Powered by Capital Market - Live News

Emmessar Biotech & Nutrition will hold a meeting of the Board of Directors of the Company on 7 November 2024Powered by Capital Market - Live News

Emmessar Biotech & Nutrition announced that the 32th Annual General Meeting (AGM) of the company will be held on 27 September 2024.Powered by Capital Market - Live News

Net profit of Emmessar Biotech & Nutrition rose 80.00% to Rs 0.09 crore in the quarter ended June 2024 as against Rs 0.05 crore during the previous quarter ended June 2023. Sales rose 14.29% to Rs 0.08 crore in the quarter ended June 2024 as against Rs 0.07 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales0.080.07 14 OPM %-350.00-400.00 - PBDT0.180.18 0 PBT0.160.16 0 NP0.090.05 80 Powered by Capital Market - Live News

Emmessar Biotech & Nutrition will hold a meeting of the Board of Directors of the Company on 14 August 2024.Powered by Capital Market - Live News